Vr Adviser, LLC Merus N.V. Transaction History
Vr Adviser, LLC
- $606 Million
- Q4 2024
A detailed history of Vr Adviser, LLC transactions in Merus N.V. stock. As of the latest transaction made, Vr Adviser, LLC holds 592,411 shares of MRUS stock, worth $26.6 Million. This represents 4.11% of its overall portfolio holdings.
Number of Shares
592,411
Previous 907,963
34.75%
Holding current value
$26.6 Million
Previous $45.4 Million
45.08%
% of portfolio
4.11%
Previous 4.7%
Shares
7 transactions
Others Institutions Holding MRUS
# of Institutions
201Shares Held
57.2MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$187 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$174 Million16.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$133 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$120 Million1.81% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.13MShares$95.3 Million1.3% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.06B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...